Literature DB >> 27791186

Proposing a mechanism of action for ataluren.

Nadeem Siddiqui1,2, Nahum Sonenberg3,2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27791186      PMCID： PMC5098668          DOI： 10.1073/pnas.1615548113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  15 in total

Review 1.  RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer.

Authors:  M R Culbertson
Journal:  Trends Genet       Date:  1999-02       Impact factor: 11.639

Review 2.  Translational readthrough induction of pathogenic nonsense mutations.

Authors:  Richard Kellermayer
Journal:  Eur J Med Genet       Date:  2006-05-19       Impact factor: 2.708

3.  Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression.

Authors:  Bijoyita Roy; Westley J Friesen; Yuki Tomizawa; John D Leszyk; Jin Zhuo; Briana Johnson; Jumana Dakka; Christopher R Trotta; Xiaojiao Xue; Venkateshwar Mutyam; Kim M Keeling; James A Mobley; Steven M Rowe; David M Bedwell; Ellen M Welch; Allan Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-04       Impact factor: 11.205

4.  Human gene mutation database-a biomedical information and research resource.

Authors:  M Krawczak; E V Ball; I Fenton; P D Stenson; S Abeysinghe; N Thomas; D N Cooper
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

Review 5.  Nonsense-Mediated mRNA Decay: Degradation of Defective Transcripts Is Only Part of the Story.

Authors:  Feng He; Allan Jacobson
Journal:  Annu Rev Genet       Date:  2015-10-02       Impact factor: 16.830

Review 6.  NMD: At the crossroads between translation termination and ribosome recycling.

Authors:  Alper Celik; Stephanie Kervestin; Allan Jacobson
Journal:  Biochimie       Date:  2014-11-13       Impact factor: 4.079

7.  Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers.

Authors:  Samit Hirawat; Ellen M Welch; Gary L Elfring; Valerie J Northcutt; Sergey Paushkin; Seongwoo Hwang; Eileen M Leonard; Neil G Almstead; William Ju; Stuart W Peltz; Langdon L Miller
Journal:  J Clin Pharmacol       Date:  2007-04       Impact factor: 3.126

8.  Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124.

Authors:  Douglas S Auld; Scott Lovell; Natasha Thorne; Wendy A Lea; David J Maloney; Min Shen; Ganesha Rai; Kevin P Battaile; Craig J Thomas; Anton Simeonov; Robert P Hanzlik; James Inglese
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

9.  A meta-analysis of nonsense mutations causing human genetic disease.

Authors:  Matthew Mort; Dobril Ivanov; David N Cooper; Nadia A Chuzhanova
Journal:  Hum Mutat       Date:  2008-08       Impact factor: 4.878

10.  Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression.

Authors:  Douglas S Auld; Natasha Thorne; William F Maguire; James Inglese
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205
View more
  9 in total

Review 1.  Novel Therapies for Prevention and Early Treatment of Cardiomyopathies.

Authors:  Giuliana G Repetti; Christopher N Toepfer; Jonathan G Seidman; Christine E Seidman
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

Review 2.  Current Treatment Strategies and Future Treatment Options for Dravet Syndrome.

Authors:  Julie Ziobro; Krista Eschbach; Joseph E Sullivan; Kelly G Knupp
Journal:  Curr Treat Options Neurol       Date:  2018-10-13       Impact factor: 3.598

3.  Amlexanox and UPF1 Modulate Wnt Signaling and Apoptosis in HCT-116 Colorectal Cancer Cells.

Authors:  Michael Bordonaro; Darina Lazarova
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

Review 4.  Cancer Biogenesis in Ribosomopathies.

Authors:  Sergey O Sulima; Kim R Kampen; Kim De Keersmaecker
Journal:  Cells       Date:  2019-03-11       Impact factor: 6.600

5.  CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors.

Authors:  Choongil Lee; Dong Hyun Jo; Gue-Ho Hwang; Jihyeon Yu; Jin Hyoung Kim; Se-Eun Park; Jin-Soo Kim; Jeong Hun Kim; Sangsu Bae
Journal:  Mol Ther       Date:  2019-05-24       Impact factor: 11.454

Review 6.  RNA-Targeted Therapies and High-Throughput Screening Methods.

Authors:  Siran Zhu; Saul Rooney; Gracjan Michlewski
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

7.  Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms.

Authors:  Martin Y Ng; Hong Li; Mikel D Ghelfi; Yale E Goldman; Barry S Cooperman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 11.205

Review 8.  How Ribosomes Translate Cancer.

Authors:  Sergey O Sulima; Isabel J F Hofman; Kim De Keersmaecker; Jonathan D Dinman
Journal:  Cancer Discov       Date:  2017-09-18       Impact factor: 39.397

9.  Effectiveness of pharmacological treatments in Duchenne muscular dystrophy: a protocol for a systematic review and meta-analysis.

Authors:  Carlos Pascual Morena; Vicente Martinez-Vizcaino; Celia Álvarez-Bueno; Ruben Fernández Rodríguez; Estela Jiménez López; Ana Isabel Torres-Costoso; Iván Cavero-Redondo
Journal:  BMJ Open       Date:  2019-09-06       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.